This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Aggarwal B.B.: Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals. Annu. Rev. Nutr., 2010; 30: 173–199AggarwalB.B.Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticalsAnnu. Rev. Nutr.20103017319910.1146/annurev.nutr.012809.104755314415620420526Search in Google Scholar
American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care, 2014; 37: S81–S90American Diabetes AssociationDiagnosis and classification of diabetes mellitusDiabetes Care201437S81S9010.2337/dc14-S08124357215Search in Google Scholar
Babu P.V., Liu D., Gilbert E.R.: Recent advances in understanding the anti-diabetic actions of dietary flavonoids. J. Nutr. Biochem., 2013; 24: 1777–1789BabuP.V.LiuD.GilbertE.R.Recent advances in understanding the anti-diabetic actions of dietary flavonoidsJ. Nutr. Biochem.2013241777178910.1016/j.jnutbio.2013.06.003382197724029069Search in Google Scholar
Cai E.P., Lin J.K.: Epigallocatechin gallate (EGCG) and rutin suppress the glucotoxicity through activating IRS2 and AMPK signaling in rat pancreatic β cells. J. Agric. Food Chem., 2009; 57: 9817–9827CaiE.P.LinJ.K.Epigallocatechin gallate (EGCG) and rutin suppress the glucotoxicity through activating IRS2 and AMPK signaling in rat pancreatic β cellsJ. Agric. Food Chem.2009579817982710.1021/jf902618v19803520Search in Google Scholar
Carneiro E.M., Latorraca M.Q., Araujo E., Beltrá M., Oliveras M.J., Navarro M., Berná G., Bedoya F.J., Velloso L.A., Soria B., Martin F.: Taurine supplementation modulates glucose homeostasis and islet function. J. Nutr. Biochem., 2009; 20: 503–511CarneiroE.M.LatorracaM.Q.AraujoE.BeltráM.OliverasM.J.NavarroM.BernáG.BedoyaF.J.VellosoL.A.SoriaB.MartinF.Taurine supplementation modulates glucose homeostasis and islet functionJ. Nutr. Biochem.20092050351110.1016/j.jnutbio.2008.05.00818708284Search in Google Scholar
Castellano J.M., Guinda A., Delgado T., Rada M., Cayuela J.A.: Biochemical basis of the antidiabetic activity of oleanolic acid and related pentacyclic triterpenes. Diabetes, 2013; 62: 1791–1799CastellanoJ.M.GuindaA.DelgadoT.RadaM.CayuelaJ.A.Biochemical basis of the antidiabetic activity of oleanolic acid and related pentacyclic triterpenesDiabetes2013621791179910.2337/db12-1215366162523704520Search in Google Scholar
Castro M.C., Francini F., Gagliardino J.J., Massa M.L.: Lipoic acid prevents fructose-induced changes in liver carbohydrate metabolism: Role of oxidative stress. Biochim. Biophys. Acta, 2014; 1840: 1145–1151CastroM.C.FranciniF.GagliardinoJ.J.MassaM.L.Lipoic acid prevents fructose-induced changes in liver carbohydrate metabolism: Role of oxidative stressBiochim. Biophys. Acta201418401145115110.1016/j.bbagen.2013.12.00524361606Search in Google Scholar
Cobianchi L., Fornoni A., Pileggi A., Molano R.D., Sanabria N.Y., Gonzalez-Quintana J., Bocca N., Marzorati S., Zahr E., Hogan A.R., Ricordi C., Inverardi L.: Riboflavin inhibits IL-6 expression and p38 activation in islet cells. Cell Transplant., 2008; 17: 559–566CobianchiL.FornoniA.PileggiA.MolanoR.D.SanabriaN.Y.Gonzalez-QuintanaJ.BoccaN.MarzoratiS.ZahrE.HoganA.R.RicordiC.InverardiL.Riboflavin inhibits IL-6 expression and p38 activation in islet cellsCell Transplant.20081755956610.3727/09636890878509606018714675Search in Google Scholar
Corless M., Kiely A., McClenaghan N.H., Flatt P.R., Newsholme P.: Glutamine regulates expression of key transcription factor, signal transduction, metabolic gene, and protein expression in a clonal pancreatic β-cell line. J. Endocrinol., 2006; 190: 719–727CorlessM.KielyA.McClenaghanN.H.FlattP.R.NewsholmeP.Glutamine regulates expression of key transcription factor, signal transduction, metabolic gene, and protein expression in a clonal pancreatic β-cell lineJ. Endocrinol.200619071972710.1677/joe.1.0689217003273Search in Google Scholar
Definicja, rozpoznawanie i klasyfikacja cukrzycy Raport Grupy Konsultacyjnej WHO (1999). Medycyna Praktyczna 2000/01. https://www.mp.pl/artykuly/1161,definicja-rozpoznawanie-i-klasyfikacjacukrzycyraport-grupy-konsultacyjnej-who-1999 (18.04.2020)Definicja, rozpoznawanie i klasyfikacja cukrzycy Raport Grupy Konsultacyjnej WHO1999Medycyna Praktyczna 2000/01https://www.mp.pl/artykuly/1161,definicja-rozpoznawanie-i-klasyfikacjacukrzycyraport-grupy-konsultacyjnej-who-1999 (18.04.2020)Search in Google Scholar
Diaz-Gerevini G.T., Repossi G., Dain A., Tarres M.C., Das U.N., Eynard A.R.: Beneficial action of resveratrol: How and why? Nutrition, 2016; 32: 174–178Diaz-GereviniG.T.RepossiG.DainA.TarresM.C.DasU.N.EynardA.R.Beneficial action of resveratrol: How and why?Nutrition20163217417810.1016/j.nut.2015.08.01726706021Search in Google Scholar
Dong H., Wang N., Zhao L., Lu F.: Berberine in the treatment of type 2 diabetes mellitus: A systemic review and meta-analysis. Evid. Based Complement. Alternat. Med., 2012; 2012: 591654DongH.WangN.ZhaoL.LuF.Berberine in the treatment of type 2 diabetes mellitus: A systemic review and meta-analysisEvid. Based Complement. Alternat. Med.2012201259165410.1155/2012/591654347887423118793Search in Google Scholar
Fenech M., El-Sohemy A., Cahill L., Ferguson L.R., French T.A.C., Tai E.S., Milner J., Koh W.P., Xie L., Zucker M., Buckley M., Cosgrove L., Lockett T., Fung K.Y., Head R.: Nutrigenetics and nutrigenomics: Viewpoints on the current status and applications in nutrition research and practice. J. Nutrigenet. Nutrigenomics, 2011; 4: 69–89FenechM.El-SohemyA.CahillL.FergusonL.R.FrenchT.A.C.TaiE.S.MilnerJ.KohW.P.XieL.ZuckerM.BuckleyM.CosgroveL.LockettT.FungK.Y.HeadR.Nutrigenetics and nutrigenomics: Viewpoints on the current status and applications in nutrition research and practiceJ. Nutrigenet. Nutrigenomics20114698910.1159/000327772312154621625170Search in Google Scholar
Fowler M.J.: Leczenie cukrzycy: Doustne leki przeciwcukrzycowe. Diabetol. Dypl., 2010; 7: 30–33FowlerM.J.Leczenie cukrzycy: Doustne leki przeciwcukrzycoweDiabetol. Dypl.201073033Search in Google Scholar
Fu Z., Zhang W., Zhen W., Lum H., Nadler J., Bassaganya-Riera J., Jia Z., Wang Y., Misra H., Liu D.: Genistein induces pancreatic β-cell proliferation through activation of multiple signaling pathways and prevents insulin-deficient diabetes in mice. Endocrinology, 2010; 151: 3026–3037FuZ.ZhangW.ZhenW.LumH.NadlerJ.Bassaganya-RieraJ.JiaZ.WangY.MisraH.LiuD.Genistein induces pancreatic β-cell proliferation through activation of multiple signaling pathways and prevents insulin-deficient diabetes in miceEndocrinology20101513026303710.1210/en.2009-1294290394220484465Search in Google Scholar
Gijsbers L., Ding E.L., Malik V.S., de Goede J., Geleijnse J.M., Soedamah-Muthu S.S.: Consumption of dairy foods and diabetes incidence: A dose-response meta-analysis of observational studies. Am. J. Clin. Nutr. 2016; 103: 1111–1124GijsbersL.DingE.L.MalikV.S.de GoedeJ.GeleijnseJ.M.Soedamah-MuthuS.S.Consumption of dairy foods and diabetes incidence: A dose-response meta-analysis of observational studiesAm. J. Clin. Nutr20161031111112410.3945/ajcn.115.12321626912494Search in Google Scholar
GUS. Infografika – Światowy Dzień Walki z Cukrzycą (14 listopada). https://stat.gov.pl/download/gfx/portalinformacyjny/pl/defaultaktualnosci/5866/46/3/1/cukrzyca_2018-01.jpg (15.04.2020)GUSInfografika – Światowy Dzień Walki z Cukrzycą (14 listopada)https://stat.gov.pl/download/gfx/portalinformacyjny/pl/defaultaktualnosci/5866/46/3/1/cukrzyca_2018-01.jpg (15.04.2020)Search in Google Scholar
Hagman D.K., Hays L.B., Parazzoli S.D., Poitout V.: Palmitate inhibits insulin gene expression by altering PDX-1 nuclear localization and reducing MafA expression in isolated rat islets of Langerhans. J. Biol. Chem., 2005; 280: 32413–32418HagmanD.K.HaysL.B.ParazzoliS.D.PoitoutV.Palmitate inhibits insulin gene expression by altering PDX-1 nuclear localization and reducing MafA expression in isolated rat islets of LangerhansJ. Biol. Chem.2005280324133241810.1074/jbc.M506000200136126715944145Search in Google Scholar
Hall E., Dayeh T., Kirkpatrick C.L., Wollheim C.B., Dekker Nitert M., Ling C.: DNA methylation of the glucagon-like peptide 1 receptor (GLP1R) in human pancreatic islets. BMC Med. Genet., 2013; 14: 76HallE.DayehT.KirkpatrickC.L.WollheimC.B.Dekker NitertM.LingC.DNA methylation of the glucagon-like peptide 1 receptor (GLP1R) in human pancreatic isletsBMC Med. Genet.2013147610.1186/1471-2350-14-76372796023879380Search in Google Scholar
Hindorff L.A., MacArthur J., Morales J., Junkins H.A., Hall P.N., Klemm A.K., Manolio T.A.: A Catalog of Published Genome-Wide Association Studies. http://www.genome.gov/gwastudies (20.04.2020)HindorffL.A.MacArthurJ.MoralesJ.JunkinsH.A.HallP.N.KlemmA.K.ManolioT.A.A Catalog of Published Genome-Wide Association Studieshttp://www.genome.gov/gwastudies (20.04.2020)Search in Google Scholar
Kobori M., Masumoto S., Akimoto Y., Takahashi Y.: Dietary quercetin alleviates diabetic symptoms and reduces streptozotocin-induced disturbance of hepatic gene expression in mice. Mol. Nutr. Food Res., 2009; 53: 859–868KoboriM.MasumotoS.AkimotoY.TakahashiY.Dietary quercetin alleviates diabetic symptoms and reduces streptozotocin-induced disturbance of hepatic gene expression in miceMol. Nutr. Food Res.20095385986810.1002/mnfr.20080031019496084Search in Google Scholar
Kozek E.: Insulin resistance and hyperinsulinemia – clinical aspects. Przegl. Lek., 1996; 53: 647–652KozekE.Insulin resistance and hyperinsulinemia – clinical aspectsPrzegl. Lek.199653647652Search in Google Scholar
Lazo de la Vega-Monroy M.L., Larrieta E., German M.S., Baez-Saldana A., Fernandez-Mejia C.: Effects of biotin supplementation in the diet on insulin secretion, islet gene expression, glucose homeostasis and beta-cell proportion. J. Nutr. Biochem., 2013; 24: 169–177Lazo de la Vega-MonroyM.L.LarrietaE.GermanM.S.Baez-SaldanaA.Fernandez-MejiaC.Effects of biotin supplementation in the diet on insulin secretion, islet gene expression, glucose homeostasis and beta-cell proportionJ. Nutr. Biochem.20132416917710.1016/j.jnutbio.2012.03.02022841397Search in Google Scholar
Lewicki S., Lewicka A., Kalicki B., Sobolewska-Ruta A., Debski B., Zdanowski R., Syryło T., Kloc M., Kubiak J.Z.: Effects of genistein on insulin pathway-related genes in mouse differentiated myoblast C2C12 cell line: Evidence for two independent modes of action. Folia Histochem. Cytobiol., 2018; 56: 123–132LewickiS.LewickaA.KalickiB.Sobolewska-RutaA.DebskiB.ZdanowskiR.SyryłoT.KlocM.KubiakJ.Z.Effects of genistein on insulin pathway-related genes in mouse differentiated myoblast C2C12 cell line: Evidence for two independent modes of actionFolia Histochem. Cytobiol.20185612313210.5603/FHC.a2018.001429998457Search in Google Scholar
Lovis P., Roggli E., Laybutt D.R., Gattesco S., Yang J.Y., Widmann C., Abderrahmani A., Regazzi R.: Alterations in microRNA expression contribute to fatty acid-induced pancreatic β-cell dysfunction. Diabetes, 2008; 57: 2728–2736LovisP.RoggliE.LaybuttD.R.GattescoS.YangJ.Y.WidmannC.AbderrahmaniA.RegazziR.Alterations in microRNA expression contribute to fatty acid-induced pancreatic β-cell dysfunctionDiabetes2008572728273610.2337/db07-1252255168318633110Search in Google Scholar
Mancini A., Imperlini E., Nigro E., Montagnese C., Daniele A., Orrù S., Buono P.: Biological and nutritional properties of palm oil and palmitic acid: Effects on health. Molecules, 2015; 20: 17339–17361ManciniA.ImperliniE.NigroE.MontagneseC.DanieleA.OrrùS.BuonoP.Biological and nutritional properties of palm oil and palmitic acid: Effects on healthMolecules201520173391736110.3390/molecules200917339633178826393565Search in Google Scholar
Miller R.G., Secrest A.M., Sharma R.K., Songer T.J., Orchard T.J.: Improvements in the life expectancy of type 1 diabetes: The Pittsburgh Epidemiology of Diabetes Complications study cohort. Diabetes, 2012; 61: 2987–2992MillerR.G.SecrestA.M.SharmaR.K.SongerT.J.OrchardT.J.Improvements in the life expectancy of type 1 diabetes: The Pittsburgh Epidemiology of Diabetes Complications study cohortDiabetes2012612987299210.2337/db11-1625347855122851572Search in Google Scholar
Mosley A.L., Corbett J.A., Ozcan S.: Glucose regulation of insulin gene expression requires the recruitment of p300 by the β-cell-specific transcription factor Pdx-1. Mol. Endocrinol., 2004; 18: 2279–2290MosleyA.L.CorbettJ.A.OzcanS.Glucose regulation of insulin gene expression requires the recruitment of p300 by the β-cell-specific transcription factor Pdx-1Mol. Endocrinol.2004182279229010.1210/me.2003-046315166251Search in Google Scholar
Patrick C., Wang G.S., Lefebvre D.E., Crookshank J.A., Sonier B., Eberhard C., Mojibian M., Kennedy C.R., Brooks S.P., Kalmokoff M.L., Maglio M., Troncone R., Poussier P., Scott F.W.: Promotion of autoimmune diabetes by cereal diet in the presence or absence of microbes associated with gut immune activation, regulatory imbalance, and altered cathelicidin antimicrobial peptide. Diabetes, 2013; 62: 2036–2047PatrickC.WangG.S.LefebvreD.E.CrookshankJ.A.SonierB.EberhardC.MojibianM.KennedyC.R.BrooksS.P.KalmokoffM.L.MaglioM.TronconeR.PoussierP.ScottF.W.Promotion of autoimmune diabetes by cereal diet in the presence or absence of microbes associated with gut immune activation, regulatory imbalance, and altered cathelicidin antimicrobial peptideDiabetes2013622036204710.2337/db12-1243366160323349499Search in Google Scholar
Phillips C.M.: Nutrigenetics and metabolic disease: Current status and implications for personalised nutrition. Nutrients, 2013; 5: 32–57PhillipsC.M.Nutrigenetics and metabolic disease: Current status and implications for personalised nutritionNutrients20135325710.1201/b16307-3Search in Google Scholar
Poitout V., Hagman D., Stein R., Artner I., Robertson R.P., Harmon J.S.: Regulation of the insulin gene by glucose and fatty acids. J. Nutr., 2006; 136: 873–876PoitoutV.HagmanD.SteinR.ArtnerI.RobertsonR.P.HarmonJ.S.Regulation of the insulin gene by glucose and fatty acidsJ. Nutr.200613687387610.1093/jn/136.4.873185325916549443Search in Google Scholar
Poitout V., Robertson R.P.: Glucolipotoxicity: Fuel excess and β-cell dysfunction. Endocr. Rev., 2008; 29: 351–366PoitoutV.RobertsonR.P.Glucolipotoxicity: Fuel excess and β-cell dysfunctionEndocr. Rev.20082935136610.1210/er.2007-0023252885818048763Search in Google Scholar
Qiu L.; List E.O.; Kopchick J.J.: Differentially expressed proteins in the pancreas of diet-induced diabetic mice. Mol. Cell. Proteomics, 2005; 4: 1311–1318QiuL.ListE.O.KopchickJ.J.Differentially expressed proteins in the pancreas of diet-induced diabetic miceMol. Cell. Proteomics200541311131810.1074/mcp.M500016-MCP20015961380Search in Google Scholar
Rojas A., Carrasco M., Delgado I., Cobo N., Tejedo J.R., Bedoya F.J., Gauthier B., Soria B., Martín F.: Signaling pathways and transcription factors involved in pancreatic islet development. In: Islam S., editor. Adv. Exp. Med. Biol.: The Islets of Langerhans 2. Springer; Berlin, Germany, 2014; 109–128RojasA.CarrascoM.DelgadoI.CoboN.TejedoJ.R.BedoyaF.J.GauthierB.SoriaB.MartínF.Signaling pathways and transcription factors involved in pancreatic islet developmentIn:IslamS.editor.Adv. Exp. Med. Biol.: The Islets of Langerhans 2SpringerBerlin, Germany2014109128Search in Google Scholar
Różańska D., Regulska-Ilow A.: The significance of anthocyanins in the prevention and treatment of type 2 diabetes. Adv. Clin. Exp. Med., 2018; 27: 135–142RóżańskaD.Regulska-IlowA.The significance of anthocyanins in the prevention and treatment of type 2 diabetesAdv. Clin. Exp. Med.20182713514210.17219/acem/6498329521054Search in Google Scholar
Sakaguchi S., Ono M., Setoguchi R., Yagi H., Hori S., Fehervari Z., Shimizu J., Takahashi T., Nomura T.: Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol. Rev., 2006; 212: 8–27SakaguchiS.OnoM.SetoguchiR.YagiH.HoriS.FehervariZ.ShimizuJ.TakahashiT.NomuraT.Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune diseaseImmunol. Rev.200621282710.1111/j.0105-2896.2006.00427.x16903903Search in Google Scholar
Sales N.M., Pelegrini P.B., Goersch M.C.: Nutrigenomics: Definitions and advances of this new science. J. Nutr. Metab., 2014; 2014: 202759SalesN.M.PelegriniP.B.GoerschM.C.Nutrigenomics: Definitions and advances of this new scienceJ. Nutr. Metab.2014201420275910.1155/2014/202759398486024795820Search in Google Scholar
Salmond R.J., Filby A., Qureshi I., Caserta S., Zamoyska R.: T-cell receptor proximal signaling via the Src-family kinases, Lck and Fyn, influences T-cell activation, differentiation, and tolerance. Immunol. Rev., 2009; 228: 9–22SalmondR.J.FilbyA.QureshiI.CasertaS.ZamoyskaR.T-cell receptor proximal signaling via the Src-family kinases, Lck and Fyn, influences T-cell activation, differentiation, and toleranceImmunol. Rev.200922892210.1111/j.1600-065X.2008.00745.x19290918Search in Google Scholar
Sommese L., Zullo A., Mancini F.P., Fabbricini R., Soricelli A., Napoli C.: Clinical relevance of epigenetics in the onset and management of type 2 diabetes mellitus. Epigenetics, 2017; 12: 401–415SommeseL.ZulloA.ManciniF.P.FabbriciniR.SoricelliA.NapoliC.Clinical relevance of epigenetics in the onset and management of type 2 diabetes mellitusEpigenetics20171240141510.1080/15592294.2016.1278097550121128059593Search in Google Scholar
Temelkova-Kurktschiev T., Stefanov T.: Life style and genetics in obesity and type 2 diabetes. Exp. Clin. Endocrinol. Diabetes, 2012; 120: 1–6Temelkova-KurktschievT.StefanovT.Life style and genetics in obesity and type 2 diabetesExp. Clin. Endocrinol. Diabetes20121201610.1055/s-0031-128583221915815Search in Google Scholar
Udupa A., Nahar P., Shah S., Kshirsagar M., Ghongane B.: A comparative study of effects of omega-3 fatty acids, alpha lipoic acid and vitamin E in type 2 diabetes mellitus. Ann. Med. Health Sci. Res., 2013; 3: 442–446UdupaA.NaharP.ShahS.KshirsagarM.GhonganeB.A comparative study of effects of omega-3 fatty acids, alpha lipoic acid and vitamin E in type 2 diabetes mellitusAnn. Med. Health Sci. Res.2013344244610.4103/2141-9248.117954379345624116330Search in Google Scholar
Vallianou N.G., Evangelopoulos A., Kazazis C.: Resveratrol and diabetes. Rev. Diabet. Stud., 2013; 10: 236–242VallianouN.G.EvangelopoulosA.KazazisC.Resveratrol and diabetesRev. Diabet. Stud.20131023624210.1900/RDS.2013.10.236416001024841877Search in Google Scholar
Wedick N.M., Pan A., Cassidy A., Rimm E.B., Sampson L., Rosner B., Willett W., Hu F.B., Sun Q., van Dam R.M.: Dietary flavonoid intakes and risk of type 2 diabetes in US men and women. Am. J. Clin. Nutr., 2012; 95: 925–933WedickN.M.PanA.CassidyA.RimmE.B.SampsonL.RosnerB.WillettW.HuF.B.SunQ.van DamR.M.Dietary flavonoid intakes and risk of type 2 diabetes in US men and womenAm. J. Clin. Nutr.20129592593310.4016/39918.01Search in Google Scholar
Witkowski M., Tabaraie T., Steffens D., Friebel J., Dörner A., Skurk C., Witkowski M., Stratmann B., Tschoepe D., Landmesser U., Rauch U.: MicroRNA-19a contributes to the epigenetic regulation of tissue factor in diabetes. Cardiovasc. Diabetol., 2018; 17: 34WitkowskiM.TabaraieT.SteffensD.FriebelJ.DörnerA.SkurkC.WitkowskiM.StratmannB.TschoepeD.LandmesserU.RauchU.MicroRNA-19a contributes to the epigenetic regulation of tissue factor in diabetesCardiovasc. Diabetol.2018173410.1186/s12933-018-0678-z638922229477147Search in Google Scholar
Wolden-Kirk H., Rondas D., Bugliani M., Korf H., Van Lommel L., Brusgaard K., Christesen H.T., Schuit F., Proost P., Masini M., Marchetti P., Eizirik D.L., Overbergh L., Mathieu C.: Discovery of molecular pathways mediating 1,25-dihydroxyvitamin D3 protection against cytokine-induced inflammation and damage of human and male mouse islets of Langerhans. Endocrinology, 2014; 155: 736–747Wolden-KirkH.RondasD.BuglianiM.KorfH.Van LommelL.BrusgaardK.ChristesenH.T.SchuitF.ProostP.MasiniM.MarchettiP.EizirikD.L.OverberghL.MathieuC.Discovery of molecular pathways mediating 1,25-dihydroxyvitamin D3 protection against cytokine-induced inflammation and damage of human and male mouse islets of LangerhansEndocrinology201415573674710.1210/en.2013-140924424042Search in Google Scholar
World Health Organisation: Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycaemia: Report of a WHO/IDF Consultation. Geneva, Switzerland, World Health Organisation, 2006. https://www.who.int/diabetes/publications/diagnosis_diabetes2006/en/ (15.04.2020)World Health Organisation: Definition and Diagnosis of Diabetes Mellitus and Intermediate HyperglycaemiaReport of a WHO/IDF ConsultationGeneva, SwitzerlandWorld Health Organisation2006https://www.who.int/diabetes/publications/diagnosis_diabetes2006/en/ (15.04.2020)Search in Google Scholar
World Health Organization: Global Report on Diabetes. Geneva 2016. https://apps.who.int/iris/bitstream/handle/10665/204871/9789241565257_eng.pdf (15.04.2020)World Health OrganizationGlobal Report on DiabetesGeneva2016https://apps.who.int/iris/bitstream/handle/10665/204871/9789241565257_eng.pdf (15.04.2020)Search in Google Scholar
Xu G., Kwon G., Cruz W.S., Marshall C.A., McDaniel M.L.: Metabolic regulation by leucine of translation initiation through the mTOR signaling pathway by pancreatic β-cells. Diabetes, 2001; 50: 353–360XuG.KwonG.CruzW.S.MarshallC.A.McDanielM.L.Metabolic regulation by leucine of translation initiation through the mTOR signaling pathway by pancreatic β-cellsDiabetes20015035336010.2337/diabetes.50.2.35311272147Search in Google Scholar
Yang B.T., Dayeh T.A., Kirkpatrick C.L., Taneera J., Kumar R., Groop L., Wollheim C.B., Nitert M.D., Ling C.: Insulin promoter DNA methylation correlates negatively with insulin gene expression and positively with HbA(1c) levels in human pancreatic islets. Diabetologia, 2011; 54: 360–367YangB.T.DayehT.A.KirkpatrickC.L.TaneeraJ.KumarR.GroopL.WollheimC.B.NitertM.D.LingC.Insulin promoter DNA methylation correlates negatively with insulin gene expression and positively with HbA(1c) levels in human pancreatic isletsDiabetologia20115436036710.1007/s00125-010-1967-6301731321104225Search in Google Scholar
Yang B.T., Dayeh T.A., Volkov P.A., Kirkpatrick C.L., Malmgren S., Jing X., Renström E., Wollheim C.B., Nitert M.D., Ling C.: Increased DNA methylation and decreased expression of PDX-1 in pancreatic islets from patients with type 2 diabetes. Mol. Endocrinol., 2012; 26: 1203–1212YangB.T.DayehT.A.VolkovP.A.KirkpatrickC.L.MalmgrenS.JingX.RenströmE.WollheimC.B.NitertM.D.LingC.Increased DNA methylation and decreased expression of PDX-1 in pancreatic islets from patients with type 2 diabetesMol. Endocrinol.2012261203121210.1210/me.2012-1004541699822570331Search in Google Scholar
Ye D.Z., Tai M.H., Linning K.D., Szabo C., Olson L.K.: MafA expression and insulin promoter activity are induced by nicotinamide and related compounds in INS-1 pancreatic β-cells. Diabetes, 2006; 55: 742–750YeD.Z.TaiM.H.LinningK.D.SzaboC.OlsonL.K.MafA expression and insulin promoter activity are induced by nicotinamide and related compounds in INS-1 pancreatic β-cellsDiabetes20065574275010.2337/diabetes.55.03.06.db05-065316505238Search in Google Scholar
Yu C., Chen Y., Cline G.W., Zhang D., Zong H., Wang Y., Bergeron R., Kim J.K., Cushman S.W., Cooney G.J., Atcheson B., White M.F., Kraegen E.W., Shulman G.I.: Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J. Biol. Chem., 2002; 277: 50230–50236YuC.ChenY.ClineG.W.ZhangD.ZongH.WangY.BergeronR.KimJ.K.CushmanS.W.CooneyG.J.AtchesonB.WhiteM.F.KraegenE.W.ShulmanG.I.Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscleJ. Biol. Chem.2002277502305023610.1074/jbc.M20095820012006582Search in Google Scholar
Zalecenia PTD: Zalecenia kliniczne dotyczące postępowania u chorych na cukrzycę 2016. Stanowisko Polskiego Towarzystwa Diabetologicznego. Diabetol Klin. 2016; 5: Supl. AZalecenia PTDZalecenia kliniczne dotyczące postępowania u chorych na cukrzycę 2016. Stanowisko Polskiego Towarzystwa DiabetologicznegoDiabetol Klin20165Supl. ASearch in Google Scholar
Zanda M., Onengut-Gumuscu S., Walker N., Shtir C., Gallo D., Wallace C., Smyth D., Todd J.A., Hurles M.E., Plagnol V., Rich S.S.: A genome-wide assessment of the role of untagged copy number variants in type 1 diabetes. PLoS Genet., 2014; 10: e1004367ZandaM.Onengut-GumuscuS.WalkerN.ShtirC.GalloD.WallaceC.SmythD.ToddJ.A.HurlesM.E.PlagnolV.RichS.S.A genome-wide assessment of the role of untagged copy number variants in type 1 diabetesPLoS Genet201410e100436710.1371/journal.pgen.1004367403847024875393Search in Google Scholar
Zeitler P., Fu J., Tandon N., Nadeau K., Urakami T., Barrett T., Maahs D.: Type 2 diabetes in the child and adolescent. Pediatr. Diabetes, 2014; 15: 26–46ZeitlerP.FuJ.TandonN.NadeauK.UrakamiT.BarrettT.MaahsD.Type 2 diabetes in the child and adolescentPediatr. Diabetes201415264610.1111/pedi.1217925182306Search in Google Scholar
Zhang Z., Ding Y., Dai X., Wang J., Li Y.: Epigallocatechin-3-gallate protects pro-inflammatory cytokine induced injuries in insulin-producing cells through the mitochondrial pathway. Eur. J. Pharmacol., 2011; 670: 311–316ZhangZ.DingY.DaiX.WangJ.LiY.Epigallocatechin-3-gallate protects pro-inflammatory cytokine induced injuries in insulin-producing cells through the mitochondrial pathwayEur. J. Pharmacol.201167031131610.1016/j.ejphar.2011.08.03321925162Search in Google Scholar
Ziegler A.G., Nepom G.T.: Prediction and pathogenesis in type 1 diabetes. Immunity, 2010; 32: 468–478ZieglerA.G.NepomG.T.Prediction and pathogenesis in type 1 diabetesImmunity20103246847810.1016/j.immuni.2010.03.018286171620412757Search in Google Scholar